September 2024 Cannabis Stock Performance
September 2024 brought sharp moves across cannabis stocks, with a mix of rallies and pullbacks that kept investors on their toes. Prices swung, sentiment shifted, and the gap between winners and laggards widened. Below, you’ll find the month’s standouts—both the leaders and the strugglers—and a brief read on what those moves might signal.
Top Gainers in Cannabis Stocks
A handful of cannabis names posted meaningful gains this month, drawing attention back to a sector known for quick pivots. While volatility cuts both ways, September’s upside moves hinted at renewed interest in select companies and a willingness among investors to lean into momentum.
CNBX Pharmaceuticals
CNBX Pharmaceuticals led the pack, jumping 29.63%. The stock ended at $0.01, a tiny price point that can magnify percentage changes, but a move of this size still turned heads. For investors scanning for turnarounds, this kind of rally often serves as a first ping on the radar.
Pharmadrug
Pharmadrug also logged a strong month, rising 20.66% to close at $0.01. The gain underscored growing attention on lower-priced names within the space, as traders looked for signs of life in an evolving cannabis landscape.
Auxly Cannabis Group
Auxly Cannabis Group climbed 9.97%, finishing at $0.03. The advance reflects improving sentiment around the company’s execution and strategy. One month doesn’t make a trend, of course, but it can mark a shift in tone.
Affinor Growers and 4Front Ventures
Affinor Growers and 4Front Ventures rounded out the group of notable winners, rising 9.66% and 9.34%, respectively. Affinor closed at $0.03, while 4Front finished at $0.05. Together, these moves reinforced a simple theme from September: buyers were selective but present.
Other Notable Gainers
Beyond the top movers, several names posted quieter but still constructive gains. Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), and Rocky Mountain High (RMHB) rose during the month, echoing a broader—if cautious—current of optimism running through cannabis-adjacent stocks.
Insights on Declining Stocks
Not every ticker participated in the rally. Some traded lower, a reminder that the sector still carries real risk and that downside can come quickly. Understanding where losses showed up helps round out the picture for September.
Leafbuyer Technologies
Leafbuyer Technologies fell 14.29%, closing at $0.0006. At this level, even small shifts can look big on a percentage basis, yet the slide still raises questions about near-term support and momentum.
Nextleaf Solutions and Eastside Distilling
Nextleaf Solutions and Eastside Distilling also moved lower. Nextleaf declined 8.78% to $0.05, while Eastside Distilling dropped 7.96% to $1.04. These setbacks highlight how quickly sentiment can turn and how uneven performance remains across the group.
Additional Losers
Curaleaf Holdings (CURLF) and Cresco Labs (CRLBF) likewise traded down. Their moves tracked broader pressures that weighed on parts of the market in September. For investors gauging overall sector health, these declines served as a counterpoint to the month’s winners.
Understanding Market Dynamics
The cannabis stock market remains fluid. Prices reflect shifting market conditions, analyst outlooks, and investor sentiment—often all at once. September’s mix of advances and retreats illustrated that push and pull. For anyone following the space, the takeaway is straightforward: stay alert to changing conditions, watch how individual names react, and keep the broader context in view.
Frequently Asked Questions
What moved cannabis stocks in September 2024?
Prices responded to market dynamics, investor sentiment, and regulatory considerations. Together, those forces shaped the month’s rallies and pullbacks across the sector.
Which stocks led the gains this month?
CNBX Pharmaceuticals rose 29.63% to $0.01, Pharmadrug climbed 20.66% to $0.01, and Auxly Cannabis Group advanced 9.97% to $0.03. Affinor Growers (up 9.66% to $0.03) and 4Front Ventures (up 9.34% to $0.05) also stood out.
Were there other names that finished higher?
Yes. Cara Therapeutics (CARA), Corbus Pharmaceuticals (CRBP), and Rocky Mountain High (RMHB) posted gains as well, echoing a cautious but noticeable streak of optimism in September.
Which stocks declined, and by how much?
Leafbuyer Technologies fell 14.29% to $0.0006. Nextleaf Solutions slipped 8.78% to $0.05, and Eastside Distilling dropped 7.96% to $1.04. Curaleaf Holdings (CURLF) and Cresco Labs (CRLBF) also declined during the month.
What’s the overall sentiment toward cannabis stocks right now?
Mixed. Some names rallied, others fell, and the sector remained volatile. That balance of risk and opportunity defined September 2024 and continues to shape how investors approach cannabis stocks.
